RE:RE:People seeing % not value Merit in this for sure particularly the long term r&d view on kai. It needs to pay its way short term hence the testing. The biggest issue for me with the kits is not the form or the cost, its the distribution method - in home, mail it in, wait, get results. If you distribute and enable the taking of the tests via the rexall deal and in the clinics you cut that bit out. Here's my other take. Canada and many other western countries haven't returned to physical work locations en masse yet and won't for a while. To get people back you will need not only government but employers (corporations) to use testing at scale and with frequency. The medipro partnership is the big news here and sheila copps as spokesperson means government access and corporate clients on both the testing and clinical side. Big game hunting.